News

Article

PharmTech Sponsored eBooks

PharmTech Sponsored eBooks

PharmTech Sponsored eBooks-05-01-2020
VolumeSponsored eBook
Issue 6
Pages: 44–45,58

Complications in Process Simulation Execution

Author(s):

Regulators have exaggerated expectations for simulated media fills.

In the late 1970s, media fill studies began to be used in aseptic processing for the expressed purpose of evaluating sterility assurance levels in filling activities. These initial studies were simplistic. In response to regulatory expectations, the activity grew in sophistication to address perceived vulnerabilities (1). 

Read this article in Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing, May 2020, May 2020 Pages: 10–14

Article details

Pharmaceutical Technology eBook: Biologics and Sterile Drug Manufacturing
May 2020
Pages: 10–14

Citation 

When referring to this article, please cite it as J. Agalloco,  “Complications in Process Simulation Execution," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.